OBI Pharma, Inc. v. Biosion, Inc.
This text of OBI Pharma, Inc. v. Biosion, Inc. (OBI Pharma, Inc. v. Biosion, Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
COURT OF CHANCERY OF THE STATE OF DELAWARE
KATHALEEN ST. J. MCCORMICK LEONARD L. WILLIAMS JUSTICE CENTER CHANCELLOR 500 N. KING STREET, SUITE 11400 WILMINGTON, DELAWARE 19801-3734
September 26, 2025
John D. Hendershot T. Brad Davey Kevin M. Gallagher Shira R. Freiman Elizabeth J. Freud Potter Anderson & Corroon LLP Richards, Layton & Finger, P.A. 1313 N. Market Street, 6th Floor One Rodney Square Wilmington, DE 19801 920 North King Street Wilmington, DE 19801
Re: OBI Pharma, Inc. v. Biosion, Inc., C.A. No. 2025-0965-KSJM
Dear Counsel:
This action arises under the Delaware Rapid Arbitration Act (the “DRAA”),
and this letter constitutes an Order under Section 5805(b) of the DRAA.1
Petitioner OBI Pharma, Inc. and Respondent Biosion, Inc. are parties to an
agreement dated December 8, 2021, which was amended on July 7, 2023 (the
“Agreement”). Section 18.2 of the Agreement provides that any “Dispute,” as
defined in the Agreement, that “is not resolved as provided in Section 18.1,” must be
“arbitrated pursuant to the Delaware Rapid Arbitration Act, 10 Del. C § 5801, et
seq.”2 It further provides for a panel of three arbitrators, but it does not name or
provide a process for selecting arbitrators.
Disputes arose between the parties. After the parties completed the pre-
arbitration procedures called for by Section 18.1, Petitioner filed this action seeking
1 See generally 10 Del. C. §§ 5801–12.
2 C.A. No. 2025-0965-KSJM Docket (“Dkt.”) 1 ¶ 4. C.A. No. 2025-0965-KSJM September 26, 2025 Page 2 of 3
appointment of three arbitrators under the DRAA. Respondent agreed to submit
names to the court for selection. On September 19, 2025, the parties jointly filed a
list of six arbitrators, all of whom are qualified under Section 5805(b) of the DRAA.3
I appoint Ret. Judge Joseph Farnan Jr., Ret. Vice Chancellor Sam Glasscock
III, and Ret. Vice Chancellor Joseph Slights III to preside over the Disputes
between the parties in accordance with the Agreement.
In 2015, the Delaware Supreme Court adopted rules to govern the procedure
in arbitrations under the DRAA. They are available on the Court’s website.
For the benefit of the parties and the appointed arbitrators, I note that the
filing of this letter officially commences the Arbitration under DRAA Rule 9, which
provides that “[i]f a petition or application for appointment of an Arbitrator is filed
with the Court of Chancery (whether on a consensual basis or otherwise), then an
Arbitration under the Act is commenced upon entry of an order by the Court of
Chancery under 10 Del. C. § 5805(b) appointing an Arbitrator[.]”4
I also note that Rule 9 provides that the appointed arbitrators must file “with
the Court of Chancery and serve upon the parties a written notice of acceptance of
appointment as Arbitrator. The notice of acceptance shall set forth the Arbitrator’s
postal and electronic mail addresses and telephone and fax numbers, and shall
specify the form in which written submissions to the Arbitrator shall be made.”5
The obligation to provide fax numbers is hereby waived.
3 See Dkt. 12 (Joint Ltr.).
4 Del. Rapid Arb. R. 9.
5 Id. C.A. No. 2025-0965-KSJM September 26, 2025 Page 3 of 3
IT IS SO ORDERED.
Sincerely,
/s/ Kathaleen St. J. McCormick
Chancellor
cc: All counsel of record (by File & ServeXpress)
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
OBI Pharma, Inc. v. Biosion, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/obi-pharma-inc-v-biosion-inc-delch-2025.